High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

By Beller U.   Halle D.   Catane R.   Kaufman B.   Hornreich G.   Levy-Lahad E.  

Gynecologic Oncology, Vol. 67, Iss. 2, 1997-11 ,pp. : 123-126

Elsevier

Access to resources Recommend Favorite

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study

By Leiserowitz Gary  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 35-36

Informa Healthcare

Access to resources Recommend Favorite

Health behaviors among Ashkenazi Jewish individuals receiving counseling for BRCA1 and BRCA2 mutations

By Quach Jackie   Porter Kyle   Leventhal Howard   Kelly Kimberly  

Familial Cancer, Vol. 8, Iss. 3, 2009-09 ,pp. : 241-250

Springer Publishing Company

Access to resources Recommend Favorite

Significantly lower rates of BRCA1/BRCA2 founder mutations in Ashkenazi women with sporadic compared with familial early onset breast cancer

By Gershoni-Baruch R.   Dagan E.   Fried G.   Bruchim Bar-Sade R.   Sverdlov-Shiri R.   Zelicksson G.   Friedman E.  

European Journal of Cancer, Vol. 36, Iss. 8, 2000-05 ,pp. : 983-986

Elsevier

Access to resources Recommend Favorite

High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia

By Torres Diana   Rashid Muhammad Usman   Gil Fabian   Umana Angela   Ramelli Giancarlo   Robledo Jose Fernando   Tawil Mauricio   Torregrosa Lilian   Briceno Ignacio   Hamann Ute  

Breast Cancer Research and Treatment, Vol. 103, Iss. 2, 2007-06 ,pp. : 225-232

Springer Publishing Company

Access to resources Recommend Favorite